CARDIOGENIC SHOCK: PAST, PRESENT, AND FUTURE CLINICAL TRIALS

Sunday, March 9, 2025

11:06 AM - 12:05 PM ET

Moderator(s)

Maya Guglin, MD

Director of Heart Failure/Transplant/MCS
Indiana University
Indianapolis, Indiana, United States

No relationships to disclose
Srihari S. Naidu, MD, FSCAI

Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States

No relationships to disclose
Alexander G. Truesdell, MD

Interventional Cardiology
Virginia Heart / Inova Schar Heart and Vascular Institute
McLean, Virginia, United States

No relationships to disclose

Disclosure(s):

Maya Guglin, MD: No financial relationships to disclose

Srihari S. Naidu, MD, FSCAI: No financial relationships to disclose

Alexander G. Truesdell, MD: Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)